Clinical Neurological Society of America

What Clinical Neurological Society of America does

The Clinical Neurological Society of America (CNSA) is a nonprofit professional medical society founded in 1974 (originally as the Southern Clinical Neurological Society, rebranded in 2021) and headquartered at 2020 K St NW Suite 505, Washington, DC. It serves practicing neurologists, neuroscientists, and allied health professionals including nurses, nurse practitioners, and advanced practice providers across the United States. Its primary purpose is to improve clinical practice and patient care through education, thought leadership, and peer community, operating as a member-run organization with a board of practicing neurologists and a small executive team led by Executive Director Michelle Winokur.

CNSA's core offerings are educational and community-based rather than technology-based. The flagship product is the Contemporary Neurology annual meeting, a CME-accredited conference (up to 21.0 AMA PRA Category 1 Credits) capped at 100 clinicians to facilitate intimate knowledge exchange, held in Florida (Key Largo 2024, Clearwater 2025, Jupiter 2026, with 2027 already committed). The CNSA Clinical Proceedings program produces expert-authored white papers, webinars, and surveys on topics including epilepsy, Parkinson's disease, Alzheimer's disease, CIDP, and other neurological conditions. The CIDP Ambassador Program, co-developed with Grifols, hosts up to 24 neuromuscular fellows per cohort for interactive training on CIDP recognition and treatment. Distribution is direct via the neuroamerica.org website, Zoom-based webinars, The Neuro Notice monthly newsletter, and social media channels.

The business model combines three revenue streams: membership dues ($200/year for General Members, $100/year for Associate Members), event registration fees ($400-$800 for Contemporary Neurology depending on member status), and Corporate Council sponsorships from pharmaceutical and biotech companies (AbbVie, Bristol Myers Squibb, Eli Lilly, Novartis, Johnson & Johnson, and others) that participate in an advisory capacity. CNSA also engages in policy advocacy through coalition partnerships with groups such as the Biologics Prescribers Collaborative, the Headache & Migraine Policy Forum, and the Movement Disorders Policy Coalition. The organization is small (11-50 employees) and does not pursue venture funding, M&A, or AI-driven product development.

Name

Clinical Neurological Society of America

Legal name

Clinical Neurological Society of America

Website

https://neuroamerica.org

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

11–50 employees

Short description

The Clinical Neurological Society of America is a nonprofit professional medical society serving U.S. neurologists and allied health professionals through CME-accredited conferences, Clinical Proceedings white papers, the CIDP Ambassador Program, webinars, and membership, funded by dues, event fees, and pharmaceutical corporate sponsorships.

Ownership category

akta.pro rank

Product category

Professional Medical Society — Neurology Continuing Education

NAICS

Business Associations (813910), Colleges, Universities, and Professional Schools (6113)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro industry

PRIMARYEDAGANAJ

Healthcare & Clinical Professional Development (CME/CE)

Education/Educational Publishing & Learning Content/Professional Development & Training Materials

Keywords

• Professional medical society
• Neurology continuing education
• Clinical neurology conferences
• Medical white papers
• CME accredited programs

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Dues: CNSA generates revenue through annual membership dues from General Members ($200/year for physicians in practice 5+ years) and Associate Members ($100/year for physicians in training, allied professionals, and retired members).
2. Event Registration Fees: Revenue from registration fees for the annual Contemporary Neurology meeting. CNSA General Member Registration is $400, CNSA Associate Member Registration is $200, and Non-member Registration is $800. Additional revenue from evening dinner event tickets ($75 adult, $25 child).
3. Corporate Council Sponsorships: Pharmaceutical and biotech companies (AbbVie, Bristol Myers Squibb, Eli Lilly, Novartis, and others) participate in the Corporate Council membership program, providing advisory perspectives and financial support.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

CNSA is a nonprofit professional medical society that delivers continuing neurology education and thought leadership to neurologists, neuroscientists, and allied health professionals across the United States. Its primary products are the annual Contemporary Neurology CME-accredited conference, the CNSA Clinical Proceedings white paper and webinar series on unmet neurology needs, the CIDP Ambassador Program for fellows, a tiered professional membership program, and The Neuro Notice monthly newsletter.

Product overview

The Clinical Neurological Society of America operates as a professional medical society offering a portfolio of educational products and services for neurologists and allied health professionals. The core offering is the Contemporary Neurology annual conference, supplemented by the CNSA Clinical Proceedings program (expert-authored white papers and companion webinars covering topics such as epilepsy, Alzheimer's disease, Parkinson's disease, synucleinopathies, CIDP, and other neurological conditions), the CIDP Ambassador Program (an interactive educational initiative developed in collaboration with Grifols), live and on-demand webinars, a monthly newsletter (The Neuro Notice), and tiered membership with General and Associate categories. The organization functions as a thought leadership and continuing medical education provider rather than a software product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Contemporary Neurology Annual Meeting CNSA's flagship annual CME-accredited conference bringing together up to 100 neurology experts for education, scientific programming, and networking, offering up to 21.0 AMA PRA Category 1 Credits. Held in Florida each January.
• CNSA Clinical Proceedings A series of expert-authored white papers, webinars, and surveys addressing unmet needs in neurology across topics such as epilepsy, Alzheimer's disease, Parkinson's disease, and CIDP, intended to advance the society's thought leadership role.
• CIDP Ambassador Program An interactive educational program for up to 24 neuromuscular and comprehensive neurology fellows on improving recognition, diagnosis, and treatment of CIDP (Chronic Inflammatory Demyelinating Polyneuropathy), developed in collaboration with Grifols.
• CNSA Membership Tiered annual professional membership for neurologists, neuroscientists, and allied health professionals, offering discounted conference registration, newsletter subscription, priority programming access, and eligibility to serve in society leadership.
• CNSA Webinars Live and on-demand webinars on neurology topics including Alzheimer's disease, epilepsy, migraine, COVID-19, and policy issues, presented by expert clinicians and researchers and hosted on Zoom.
• The Neuro Notice Newsletter Monthly e-newsletter providing updates on CNSA events, public policy developments, neurological news, member profiles, and continuing education opportunities.

Quantifiable outcome

• Epilepsy affects 1 in 26 people in the US - CNSA white paper addresses diagnosis and monitoring unit access

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

21 partnerships are on record, tiered core and minor.

• GrifolscoreStrategic or Co-development PartnerCollaboration between CNSA and Grifols on the CIDP Ambassador Program, offering up to 24 neuromuscular fellows, comprehensive neurology fellows and comprehensive neurologists the opportunity to attend an interactive educational program on improving recognition, diagnosis and treatment of CIDP.
• AbbVieminorGTM or Marketing PartnerCorporate Council member - a membership program allowing the Society's leadership to engage and share insights with representatives of companies developing biologics, pharmaceuticals, medical devices and diagnostics prescribed by clinical neurologists.
• Acadia PharmaceuticalsminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• AmnealminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• Bristol Myers SquibbminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• EisaiminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• Eli Lilly & CompanyminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• Johnson & JohnsonminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• MerzminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• Neurocrine BiosciencesminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• NovartisminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• SK Life ScienceminorGTM or Marketing PartnerCorporate Council member providing industry perspective on issues impacting clinical care, patient access and the field of neurology.
• Medical Education ResourcescoreStrategic or Co-development PartnerJoint provider of the Contemporary Neurology meeting with CNSA. This partnership enables the offering of AMA PRA Category 1 Credits for the annual conference.
• Jupiter Beach Resort & SpaminorOthersVenue for Contemporary Neurology 2026 meeting, January 17-20, 2026 in Jupiter, Florida. Group rate of $319.00 per night available for attendees.
• Biologics Prescribers CollaborativeminorStrategic or Co-development PartnerCNSA joins this stakeholder coalition to ensure sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.
• Headache & Migraine Policy ForumminorStrategic or Co-development PartnerCNSA participates in this coalition to advance public policies that promote accelerated innovation and access to treatments for people living with headache disorders and migraine disease.
• Movement Disorders Policy CoalitionminorStrategic or Co-development PartnerCNSA collaborates with this coalition to bring together advocacy groups, health care providers, patients and other stakeholders to inform policy impacting patient-centered care for people living with movement disorders.
• Patient & Provider Advocates for TelehealthminorStrategic or Co-development PartnerCNSA partners with this coalition to advance policies that ensure robust coverage and minimal access obstacles for those who rely upon telehealth.
• Association of Movement Disorder Advanced Practice Providers (AMDAPP)minorStrategic or Co-development PartnerCNSA collaborates with AMDAPP, a professional network built for APPs (by APPs!) to connect, refuel their inspiration, deep dive into further education and collaborate to enhance the lives of their patients.
• Society for Equity Neuroscience (SEQUINS)minorStrategic or Co-development PartnerCNSA collaborates with SEQUINS, whose mission is to advance brain health equity through science by emphasizing high-quality research and workforce development for high-risk populations, aiming to narrow brain health inequities and disparities.
• Society of Black NeurologistsminorStrategic or Co-development PartnerCNSA collaborates with this community dedicated to fostering discussions, mentorship, and the spirit of community among Black or African-American neurologists.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• American Academy of Neurology: The largest US professional society for neurologists, offering CME-accredited annual meetings, journals (Neurology), and member education across all neurology subspecialties — the most direct competitor for CNSA's members and sponsors.
• American Neurological Association: A historic US neurology professional society focused on academic and research neurologists; competes with CNSA for senior neurologist mindshare, leadership pipeline, and academic continuing education.
• Child Neurology Society: Professional society for pediatric neurologists offering annual meetings, CME, and subspecialty education; comparable specialty-society model serving an overlapping but distinct neurology segment.
• International Parkinson and Movement Disorder Society: Global subspecialty society for movement disorders running annual congresses and clinical education — directly comparable content vertical to CNSA's Parkinson's Disease expert panel work.
• American Epilepsy Society: Subspecialty society for epilepsy clinicians and researchers offering annual meetings, CME, and white-paper style clinical guidance — mirrors CNSA's Clinical Proceedings model in a focused therapeutic area.
• American Headache Society: Subspecialty society for headache and migraine clinicians; comparable intimate-meeting model, pharma-funded education, and clinical proceedings that overlap with CNSA's migraine content.

Broad incumbents

• Society for Neuroscience: The largest neuroscience professional society (basic and translational), with a massive annual meeting and journal (JNeurosci); overlaps CNSA's neuroscience-adjacent member segment at greater scale.
• American Psychiatric Association: Closely adjacent CNS-focused professional society; comparable dues, CME, journal, pharma council, and policy advocacy model that neurologists frequently engage with due to CNS overlap.
• American College of Physicians: A large internal-medicine professional society with the same dues + annual-meeting + CME + chapter-based member-services model; illustrates how a specialty society scales membership and product lines beyond CNSA's current footprint.
• World Federation of Neurology: International umbrella body for neurology societies; serves a similar global CME and policy-advocacy role to CNSA's coalition work but at worldwide scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/NeuroAmerica
• Facebookfacebook.com/NeuroAmerica
• LinkedInlinkedin.com/company/clinical-neurological-society-of-america

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Neurological Society of America